All News
Johns Hopkins Treats First Patient in the United States as Part of Imricor’s VISABL-AFL Clinical Trial
14 August 2024 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that...
Read On →
VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
21 June 2024 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that...
Read On →
Imricor Receives Approval from Saudi Food and Drug Authority
17 January 2024 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce it...
Read On →
Imricor Expands Middle East Footprint Into Qatar
21 December 2023 – Minneapolis, United States– Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce it has...
Read On →
Imricor Signs Joint Development Agreement with ADIS for AI Modules in NorthStar
29 November 2023 – Minneapolis, MN United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to advise that it has signed a Joint Development Agreement...
Read On →
Patient Resource: What to Expect During a Cardiac iCMR Ablation Procedure
At the Cardiology Department of Amsterdam UMC, location AMC, they are doing something groundbreaking. For about a year now, patients with certain cardiac arrhythmias have been able to come...
Read On →
Podcast: Pioneering a new standard of cardiac care – Imricor Medical Systems
Listen to the Full Podcast Equity Mates Investing co-hosts, Bryce and Ren, interview Imricor Medical Systems (ASX: IMR) CEO, Steve Wedan. In this podcast, Steve talks through Imricor, how he...
Read On →
Imricor Receives Ethics Approval to Commence VISABL-VT Trial
1 August 2023 – Minneapolis, MN United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), the global leader in real-time iCMR cardiac ablation products, is pleased to...
Read On →
Imricor Signs Landmark Agreement with Leading Distributor in Saudi Arabia
31 July 2023 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce it...
Read On →
Imricor Announces Commercial Agreement to Sell ADAS 3D Medical Software as Part of its Product Suite
Minneapolis MN (July 11 2023) – Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased announce it has entered...
Read On →
Imricor Establishes First iCMR Site in Switzerland
April 11 – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR), the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the University Hospital Lausanne (CHUV) in...
Read On →
Imricor Collaborates with GE HealthCare in Interventional Cardiac MRI
Minneapolis MN (January 25, 2023) – Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased to announce that it...
Read On →
For The First Time In Berlin: Catheter Ablation Performed with MRI Imaging
At the Helios Klinikum Berlin-Buch, catheter ablation was performed using a cardiac MRI. For the first time, a team of cardiologists has paired the standard procedure of catheter ablation with...
Read On →
Imricor Submits for Approval to Commence VT Trial in Europe
22 September 2022 – Minneapolis, MN United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR), the global leader in real-time iCMR cardiac ablation products, is pleased to announce...
Read On →
Imricor Announces Signed Agreement with Siemens Healthineers Enabling 3D Mapping System
11 August 2022 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in realtime interventional cardiac magnetic resonance (iCMR) cardiac ablation products, is...
Read On →
Imricor Announces Development Agreement with MIPM
31 March 2022 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in Realtime iCMR cardiac ablation products, is pleased to announce it...
Read On →
Imricor Leadership Team Update
11 February 2022 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, today announced the scheduled retirement...
Read On →
Imricor Adds First Site in Greece
4 January 2022 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, is pleased to announce that...
Read On →
Imricor Enrolls Two More Customer Sites in Berlin
28 December 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, is pleased to announce that...
Read On →
Semmelweis University Heart and Vascular Centre Established as Imricor’s Eleventh iCMR Site
13 October 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in iCMR-guided cardiac ablation products, is pleased to announce that the...
Read On →
Imricor Announces Sales Agreement with NordicNeuroLab
30 August 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce it has...
Read On →
Imricor’s Advantage-MR System Receives TGA Approval
lobal leader in MRI-guided cardiac ablation products, has achieved an important milestone in its geographic expansion plans with the Company’s Advantage-MR EP Recorder/Stimulator system receiving Australian TGA approval....
Read On →
Imricor Announces Distribution Agreement with Regional Health Care Group, Expanding Reach to Australia And New Zealand
2 April 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce it has...
Read On →
Leipzig Heart Centre Commences Procedures
8 March 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce the Helios...
Read On →
Maastricht Univerisity Medical Center Commences Procedures
24 February 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce the Maastricht...
Read On →
Imricor Appoints Chief Operating Officer
29 December 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products Imricor is pleased to announce that to...
Read On →
Imricor Announces Supply and Sales Agreement with Osypka
10 December 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce they have...
Read On →
Münster University Hospital Established as Imricor’s 9th iCMR Lab
24 November 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce the University...
Read On →
Schleswig-Holstein University Medical Centre Signs Purchase Agreement with Imricor
Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in iCMR guided cardiac ablation products, is pleased to announce the Schleswig-Holstein University Medical Centre (Universitätsklinikum Schleswig-Holstein, or UKSH), in Lübeck...
Read On →
Institut Cardiovasculaire Paris Sud Signs Purchase Agreement with Imricor
26 October 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in iCMR guided cardiac ablation products, is pleased to announce the...
Read On →
Maastricht University Medical Center Signs Purchase Agreement with Imricor
29 September 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products, is pleased to announce the Maastricht University...
Read On →
Rhön Clinic Bad Neustadt Campus Signs Purchase Agreement with Imricor
28 September 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products, is pleased to announce the Rhön Clinic...
Read On →
Imricor Awarded NIH Contract
27 September 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products, is pleased to announce it was awarded...
Read On →
CEO Steve Wedan Presents at the ASX Small and Mid-Cap Conference.
Imricor Medical Systems Inc (ASX:IMR) chair and CEO Steve Wedan speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020....
Read On →
Imricor Announces Sales Collaboration with Optoacoustics
12 August 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce a sales...
Read On →
Imricor Announces First Sales Collaboration with Philips
4 August 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the worldwide leader in MRI-guided cardiac ablation products, is pleased to announce the first...
Read On →
Amsterdam UMC Becomes First to Perform Cardiac Catheter Ablation in Diagnostic MRI Lab
23 June 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce the first procedure using the Company’s products in a traditional...
Read On →
Haga Hospital Becomes First in the Benelux To Perform Cardiac Catheter Ablation in the iCMR
5 June 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce, the first two successful cardiac catheter ablation procedures using the...
Read On →
Imricor Signs Agreement with German Group Purchasing Organisation, Sana
Imricor Medical Systems, Inc. is pleased to announce that it has signed a Master Purchasing Agreement with Sana Einkauf & Logistik GmbH of Ismaning Germany (Sana). Sana is the largest...
Read On →
Imricor Announces First Cases Successfully Performed At Heart Center Dresden
Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce the first procedures using the Company’s products following CE mark of the Vision-MR Ablation...
Read On →
Vision-MR Ablation Catheter Receives CE Mark
Imricor Medical Systems, Inc. (ASX:IMR) today announces that it has received CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode. This follows earlier CE mark approval for...
Read On →
Nick Twohy Joins Imricor Executive Team
Imricor Medical Systems, Inc. (ASX:IMR), a leading developer of innovative MRI-compatible medical devices, announced today Nick Twohy has joined the company’s executive team as the Director of Marketing....
Read On →
Haga Hospital in the Netherlands to Install State-of-the-Art MRI Ablation Center
Imricor announced today that they have signed a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit an MRI ablation center for treating cardiac arrhythmias....
Read On →
Amsterdam University Medical Center to be first Dutch hospital to adopt real-time MRI-guided cardiac ablations
Imricor announced today that it signed its first commercialization contract in the Netherlands with the Amsterdam University Medical Center, location VUmc, for the Advantage-MR™ EP Recorder/Stimulator System. With this agreement,...
Read On →
Heart Center Dresden to be first commercial clinical site for Imricor
Imricor announced today that it signed its first commercialization contract for the Advantage-MR EP Recorder/Stimulator System and supporting Vision-MR devices1 with the Heart Center Dresden in Germany. This agreement places...
Read On →
Imricor Announces Completion of Enrollment for Clinical Study to Evaluate Vision-MR Ablation Catheter for Real-Time MR-Guided Ablations
Imricor Medical Systems announced today the completion of enrollment for the clinical study to evaluate Imricor’s Vision-MR™ Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance. The...
Read On →
Imricor Awarded NIH Contract to Develop MR Compatible Catheter for MRI-Guided Cardiac Procedures
Imricor Medical Systems announced that it has been awarded a contract for up to $2.4 million from the National Heart, Lung, and Blood Institute of the National Institutes of Health...
Read On →
Imricor & MiRTLE Medical Announce Joint Development Agreement to Deliver 12 Lead ECG for MR-guided Cardiac Ablations
Imricor and MiRTLE Medical announce a joint development agreement to fully integrate MiRTLE’s MR compatible 12-lead ECG system with Imricor’s Advantage-MRTM EP Recorder/Stimulator System. This integration, along with Imricor’s MR...
Read On →
Imricor and Siemens Healthineers Announce Strategic Relationship to Improve Cardiac Ablations
Siemens Healthineers is joining forces with U.S.-based Imricor Medical Systems Inc. to develop an integrated solution that combines the clinical benefits of real-time MRI scans with 3D-guided cardiac ablation. The...
Read On →
Imricor Announces Enrollment of First Patients in Clinical Study to Evaluate Vision-MR Ablation Catheter for Real-Time MR-Guided Ablation Procedures
Imricor Medical Systems announced today the enrollment of the first patients in a clinical study to evaluate the Vision-MR Ablation Catheter for the treatment of atrial flutter under real-time MRI...
Read On →
Imricor Receives CE Mark for MR Compatible Advantage-MR EP Recorder and Stimulator System
Imricor Medical Systems announced today that it has received CE mark for its Advantage-MR™ EP Recorder/Stimulator System; a first-of-its-kind MR Conditional recording system for MRI-guided electrophysiology (EP) procedures. The Advantage-MR...
Read On →
Dedicated Interventional MRI EP Lab Opens in Leipzig, Germany
Imricor Medical Systems announced the dedication of Europe’s latest interventional MRI suite for electrophysiology (EP) procedures in Leipzig, Germany. With this state-of-the-art lab, Prof. Gerhard Hindricks MD, PhD and his...
Read On →
Excitement Builds for Imricor’s MR-Enabled Technology at HRS 2015
At the 2015 Heart Rhythm Society Scientific Sessions in Boston, MA, attendees gathered to learn how Imricor is making MRI-guided cardiac ablations a clinical reality. Physicians from around the world...
Read On →
Imricor Selected as Finalist for the Twin Cities AHA Innovation Grant Challenge
The American Heart Association Advancing Sciences Breakfast selected Imricor Medical Systems as a finalist for its Twin Cities Innovation Grant Challenge; a competition for Minnesota-based med-tech companies with technology related...
Read On →